Source: AZBio — 2026-08-14
Summary
Phoenix-based MiiHealth AI closed a $2.8 million seed round led by Russell Glass of Arteria Capital, the former CEO of Headspace. The company's AI agent, DAINA, autonomously conducts pre-visit patient intake — conversationally capturing clinical history and writing structured notes directly into the electronic health record (EHR) — with MiiHealth claiming it gives clinicians back roughly two hours per day otherwise spent on manual intake and charting. That two-hour figure is a vendor-reported claim from MiiHealth, not an independently audited study result.
Key Takeaways
- MiiHealth AI raised a $2.8 million seed round led by Russell Glass of Arteria Capital, who previously served as CEO of Headspace, giving the round a notable consumer-health-tech-adjacent lead investor.
- DAINA is positioned as an autonomous pre-visit intake agent, conducting the clinical history conversation with the patient before they see the clinician, rather than assisting a clinician mid-visit.
- Captured intake data is written as structured notes directly into the EHR, meaning the clinician walks into the room with a documented history already in the chart rather than needing to elicit and type it themselves.
- MiiHealth's headline claim is that DAINA gives clinicians back roughly two hours per day — this is the company's own reported figure, not a peer-reviewed or independently audited result, and should be treated as a vendor claim pending outside validation.
- The company is Phoenix-based, adding to a small but growing cluster of health-AI startups building intake and documentation tools aimed squarely at reducing clinician administrative burden.
Reel Script
Hook: A startup just raised $2.8 million on the claim that an AI can interview your patient before you even walk in the room — and hand you a finished chart note instead of a blank one. The pitch is real. The two-hour number behind it isn't independently verified yet.
Core Concept: Patient intake is one of the most repetitive, time-costly parts of a clinical visit: someone has to ask about symptoms, history, medications, and reason for visit, then turn that conversation into a structured note in the EHR before the clinician can actually start treating. DAINA's mechanism is to move that conversation earlier and off the clinician's plate entirely — the patient talks through their history with the AI agent before the visit starts, conversationally, the way they might describe their symptoms to a nurse on the phone. The agent then converts that conversation into a structured note and writes it directly into the EHR. The clinician's job shifts from "gather the history, then treat" to "read the already-captured history, then treat." That's the actual product: an agent doing the front-loaded data-gathering work autonomously, pre-visit.
Hands-On: The flow to picture is three steps: patient talks to DAINA before the appointment, in natural conversation, not a static form. DAINA converts that conversation into a structured clinical note and writes it directly into the EHR. The clinician then opens the chart at the start of the visit and the history is already there, documented, ready to review. MiiHealth says this saves clinicians about two hours a day — but that number comes from the company itself in its own funding announcement, not from a published, independently audited study, so treat it as a claim to watch for outside validation rather than a settled result.
Takeaway: The mechanism — shifting intake from clinician-led to agent-led, pre-visit — is a genuinely sound structural idea for reducing charting burden, and it's worth tracking regardless of whether the two-hour figure holds up under scrutiny. If you're evaluating a claim like this from any vendor, ask for the independently measured version of the number before you build a workflow decision around it.